Dimensional Fund Advisors LP Homology Medicines, Inc. Transaction History

Dimensional Fund Advisors LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.84 - $1.43 $2,199 - $3,745	-2,619 Reduced 2.18%	117,611 $137,000
Q2 2023 Aug 09, 2023	SELL	$0.83 - $1.12 $12,873 - $17,371	-15,510 Reduced 11.43%	120,230 $105,000
Q1 2023 May 12, 2023	SELL	$0.91 - $1.69 $19,903 - $36,963	-21,872 Reduced 13.88%	135,740 $139,000
Q4 2022 Feb 09, 2023	SELL	$1.09 - $2.04 $44,583 - $83,440	-40,902 Reduced 20.6%	157,612 $198,000
Q3 2022 Nov 10, 2022	SELL	$1.55 - $3.01 $13,652 - $26,512	-8,808 Reduced 4.25%	198,514 $320,000

Q2 2022 Aug 12, 2022	SELL	$1.39 - $3.12 $168,362 - $377,906	-121,124 Reduced 36.88%	207,322 $408,000
Q1 2022 May 13, 2022	BUY	$2.6 - $4.17 $137,173 - $220,005	52,759 Added 19.14%	328,446 $998,000
Q4 2021 Feb 09, 2022	BUY	$3.64 - $7.78 $680,883 - $1.46 Million	187,056 Added 211.05%	275,687 $1 Million
Q3 2021 Nov 12, 2021	BUY	$6.01 - $8.71 $344,366 - $499,074	57,299 Added 182.88%	88,631 $698,000
Q2 2021 Aug 12, 2021	SELL	$6.02 - $9.64 $226,689 - $363,003	-37,656 Reduced 54.58%	31,332 $228,000
Q1 2021 May 14, 2021	BUY	$9.17 - $14.8 $632,619 - $1.02 Million	68,988 New	68,988 $649,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.